Terbinafine in the treatment of Trichophyton tinea capitis: A randomized, double-blind, parallel-group, duration-finding study

Pediatrics

Volumn 109, Issue 4, 2002, Pages 602-607

  Friedlander, Sheila F ^a,j   Aly, Raza ^b   Krafchik, Bernice ^c   Blumer, Jeffrey ^d   Honig, Paul ^e   Stewart, Daniel ^f   Lucky, Anne W ^g   Gupta, Aditya K ^h   Babel, Dennis E ^f   Abrams, Bea ⁱ   Gourmala, Nouciba ⁱ   Wraith, Lindaann ⁱ   Paul, Carle ⁱ  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f Midwest Cutaneous Research Corp   (United States)

^g Dermatology Research Associates   (United States)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ NOVARTIS PHARMA AG   (Switzerland)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Terbinafine; Tinea capitis; Trichophyton species

Indexed keywords

TERBINAFINE;

ABDOMINAL PAIN; ADOLESCENT; APPETITE; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FLATULENCE; FOLLOW UP; FUNGUS CULTURE; HEADACHE; HUMAN; HYPERESTHESIA; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TINEA CAPITIS; TREATMENT OUTCOME; TRICHOPHYTON; TRICHOPHYTON TONSURANS;

ADMINISTRATION, ORAL; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTROINTESTINAL DISEASES; HEADACHE; HUMANS; MALE; NAPHTHALENES; TINEA CAPITIS;

EID: 18344389334     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.109.4.602     Document Type: Article

References (19)

1. Tinea capitis
2. Ecology, epidemiology, and diagnosis of tinea capitis
3. Tinea capitis in California children: A population-based study of a growing epidemic
4. Response to initial griseofulvin therapy in pediatric patients with tinea capitis
5. Allylamines - Mode and selectivity of action compared to azole antifungals and biological fate in mammalian organisms
6. Short-duration therapy with terbinafine for dermatophyte onychomycosis: A multicentre trial
7. Terbinafine. An update of its use in superficial mycoses
8. A randomized comparison of 4 weeks of terbinafine vs 8 weeks of griseofulvin for the treatment of tinea capitis
9. Comparison of terbinafine and griseofulvin in the treatment capitis
10. Griseofulvin and terbinafine in the treatment of tinea capitis in children
11. Comparative study of the efficacy and tolerability of 4 weeks of terbinafine therapy with 8 weeks of griseofulvin therapy in children with tinea capitis
12. A randomized double-blind comparative study of terbinafine for 1, 2, and 4 weeks in tinea capitis
13. Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis
14. Efficacy, safety, and tolerability of terbinafine for tinea capitis in children. Brazilian multicentric study with daily oral tablets for 1, 2, and 4 weeks
15. An open study of tinea capitis in 50 children treated with a 2-week course of oral terbinafine
16. Oral terbinafine in tinea capitis in children
17. Pilot study of terbinafine in children suffering from tinea capitis: Evaluation of efficacy, safety and pharmacokinetics
18. Selenium sulfide: Adjunctive therapy for tinea capitis
19. Comparison of 1% and 2.5% selenium sulfide in the treatment of tinea capitis